TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2023
Back to search
Official data from USPTO
AFFIMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AFFIMED
ST13
US500000088532843Class
1, 5, 42
Filing
88532843
Registration
6578739
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
10/06/2023
Trademark type
Word
Nice classes
1, 5, 42
Filing date
07/24/2019
Registration date
12/07/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/07/2021
Last transaction
10/06/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Mannheim, DE
Examiner
ROSEN, BENJAMIN
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Affimed GmbH
Affimed GmbH
Representatives
Shauna M. Wertheim THE MARBURY LAW GROUP, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological and biochemical preparationsin particular in form of antibodiesantibody derivativesbinding proteins and peptides for laboratory and experimentation purposesin particular for conducting experimental assaysother than for medical or veterinary purposes; biological and biochemical diagnostic preparations other than for medical or veterinary purposesin particular in form of antibodiesantibody derivativesbinding proteins and peptides
Class 5
Pharmaceutical and veterinary preparations for cancer and immuno-oncology; biological and biochemical preparations for the treatment of cancer in form of antibodiesantibody derivativesbinding proteins and peptides for medical or veterinary purposes; biological and biochemical preparations in form of bifunctional or multifunctional proteins with binding affinity to immune cellsin particular with binding affinity to T cells and natural killer (NK) cellsin particular for the subsequent targeting of cancer cells; biological and biochemical preparations for diagnostic use for medical or veterinary purposesin particular in form of antibodiesantibody derivativesbinding proteins and peptides; biological and biochemical preparations for the treatment of cancer in form of antibodiesantibody derivativesbinding proteins and peptides for use within the framework of experimental and medical or veterinary assays; biological and biochemical diagnostic preparations for medical or veterinary use in form of antibodiesantibody derivativesbinding proteins and peptides for use within the framework of medical or veterinary assays
Class 42
Scientific and technological servicesresearch and design in the field of immuno-therapyin particular in the field of immuno-oncology; scientific and technological servicesresearch and design in the field of virology; scientific and technological servicesresearch and design in the field of antiinfectives; scientific and technological servicesresearch and design in the field of neurodegenerative diseases; scientific and technological servicesresearch and design in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodiesantibody derivativesbinding proteins and peptides; scientific and technological servicesresearch and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunityin particular in the field of immune-oncology
Publications
History of USPTO decisions and trademark events.
35 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/07/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
11/03/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
09/23/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/24/2021
PUBO
PUBLISHED FOR OPPOSITION
08/24/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/21/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/20/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/20/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/29/2021
GNSL
LETTER OF SUSPENSION E-MAILED
05/29/2021
CNSL
SUSPENSION LETTER WRITTEN
05/29/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2021
ALIE
ASSIGNED TO LIE
05/28/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/02/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/07/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/07/2020
CNSI
SUSPENSION INQUIRY WRITTEN
09/07/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/07/2020
GNSL
LETTER OF SUSPENSION E-MAILED
03/07/2020
CNSL
SUSPENSION LETTER WRITTEN
03/07/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/05/2020
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
10/22/2019
GPRA
PRIORITY ACTION E-MAILED
10/22/2019
CPRA
PRIORITY ACTION WRITTEN
10/22/2019
DOCK
ASSIGNED TO EXAMINER
10/15/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2019
NWAP
NEW APPLICATION ENTERED
07/29/2019
Continuous trademark protection
Get notified about every new filing that threatens AFFIMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.